Egr1 regulates the coordinated expression of numerous EGF receptor target genes as identified by ChIP on chip

被引:37
作者
Arora, Shilpi [1 ]
Wang, Yipeng [1 ,2 ]
Jia, Zhenyu [1 ]
Vardar-Sengul, Saynur [1 ,3 ]
Munawar, Ayla [1 ]
Doctor, Kutbuddin S. [4 ]
Birrer, Michael [5 ]
McClelland, Michael [2 ]
Adamson, Eileen [1 ]
Mercola, Dan [1 ]
机构
[1] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA
[2] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA
[3] Ege Univ, Sch Dent, Dept Periodontol, TR-35100 Izmir, Turkey
[4] Burnham Inst Med Res, La Jolla, CA 92037 USA
[5] NCI, NIH, Cell & Canc Biol Res, Bethesda, MD 20892 USA
关键词
D O I
10.1186/gb-2008-9-11-r166
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: UV irradiation activates the EGF receptor, induces Egr1 expression and promotes apoptosis in a variety of cell types. We examined the hypothesis that Egr1 regulates genes that mediate this process by use of a chip-on-chip protocol in human tumorigenic prostate M12 cells. Results: UV irradiation led to significant binding of 288 gene promoters by Egr1. A major functional subgroup consisted of apoptosis related genes. The largest subgroup of 24 genes; belong to the EGFR-signal transduction pathway. Egr1 promoter binding had a significant impact on gene expression of target genes. Conventional ChIP and qRTPCR were used to validate promoter binding and expression changes. siRNA experiments were used to demonstrate the specific role of Egr1 in gene regulation. UV-stimulation promotes growth arrest and apoptosis of M12 cells and our data clearly show that downstream target of EGFR, namely Egr1, mediates this apoptotic response. Our study also identified numerous previously unknown targets of Egr1. These include FasL, MAX and RRAS2, which may play a role in the apoptotic response/growth arrest. Conclusion: Our results indicate that M12 cells undergo Egr1-dependent apoptotic response upon UV-stimulation and led to the identification of downstream targets of Egr1, which mediate EGFR function.
引用
收藏
页数:36
相关论文
共 48 条
[1]   Mechanisms of prostate tumorigenesis: Roles for transcription factors Nkx3.1 and Egr1 [J].
Abdulkadir, SA .
TUMOR PROGRESSION AND THERAPEUTIC RESISTANCE, 2005, 1059 :33-40
[2]   Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors [J].
Ahmed, MM .
CURRENT CANCER DRUG TARGETS, 2004, 4 (01) :43-52
[3]   The zinc finger transcription factor Egr-1 is upregulated in arsenite-treated human keratinocytes [J].
Al-Sarraj, A ;
Thiel, G .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2004, 82 (08) :530-538
[4]   The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFβ1, PTEN, p53, and fibronectin [J].
Baron, V ;
Adamson, ED ;
Calogero, A ;
Ragona, G ;
Mercola, D .
CANCER GENE THERAPY, 2006, 13 (02) :115-124
[5]   Antisense to the early growth response-1 gene (Egr-1) inhibits prostate tumor development in TRAMP mice [J].
Baron, V ;
Duss, S ;
Rhim, JH ;
Mercola, D .
THERAPEUTIC OLIGONUCLEOTIDES: ANTISENSE, RNAI, TRIPLE-HELIX, GENE REPAIR, ENHANCER DECOYS, CPG AND DNA CHIPS, 2003, 1002 :197-216
[6]   Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo [J].
Baron, V ;
De Gregorio, G ;
Krones-Herzig, A ;
Virolle, T ;
Calogero, A ;
Urcis, R ;
Mercola, D .
ONCOGENE, 2003, 22 (27) :4194-4204
[7]   TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax [J].
Bellot, G. ;
Cartron, P. -F. ;
Er, E. ;
Oliver, L. ;
Juin, P. ;
Armstrong, L. C. ;
Bornstein, P. ;
Mihara, K. ;
Manon, S. ;
Vallette, F. M. .
CELL DEATH AND DIFFERENTIATION, 2007, 14 (04) :785-794
[8]  
BERNSTEIN SH, 1991, CELL GROWTH DIFFER, V2, P273
[9]   ISOLATION AND CHARACTERIZATION OF A ZINC FINGER POLYPEPTIDE GENE AT THE HUMAN CHROMOSOME-11 WILMS TUMOR LOCUS [J].
CALL, KM ;
GLASER, T ;
ITO, CY ;
BUCKLER, AJ ;
PELLETIER, J ;
HABER, DA ;
ROSE, EA ;
KRAL, A ;
YEGER, H ;
LEWIS, WH ;
JONES, C ;
HOUSMAN, DE .
CELL, 1990, 60 (03) :509-520
[10]  
Calogero A, 2001, CLIN CANCER RES, V7, P2788